Skip to main navigation Skip to search Skip to main content

RACGP chair Mark Morgan calls on federal government to incentivise onshore IV manufacturing industry as medicine cost soars 10 fold in national shortage crisis

Press/Media: Expert Comment

Description

A top medico has urged the federal government to incentivise a local manufacturing industry for critical medical supplies as the cost of imported IV soars 10 fold in a shortage...

Mr Morgan told the publication ­incentivising manufacturing onshore could mean the nation has guaranteed access to core medical supplies, reducing the enormous pressure on hospitals.

“It might not be as profitable for a company to manufacture medical supplies in Australia but Australia does need to have a guaranteed access to a core set of supplies and that might mean ­incentivising manufacturing onshore,” he said.

“Australia needs the capacity to manufacture essentials onshore, even if this means using taxpayers’ money to build incentives. Australia should take a disaster planning approach to essential supplies.

“A planned, responsive, staged alerting system for supplies that might become shortages, and then do become shortages, I think a lot can be learnt from the disaster planning we have in this country and the same should happen for medical supplies.”

Subject

Medicine Shortages

Period17 Aug 2024

Media contributions

1

Media contributions